Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 2.
Article
Hall, MR;
Dehbi, H-M;
Banerjee, S;
Lord, R;
Clamp, A;
Ledermann, JA;
Nicum, S;
... Rustin, G; + view all
(2020)
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.
Gynecologic Oncology
, 159
(3)
pp. 692-698.
10.1016/j.ygyno.2020.09.048.
|
|
Roncolato, FT;
Joly, F;
O'Connell, R;
Lanceley, A;
Hilpert, F;
Buizen, L;
Okamoto, A;
... Friedlander, M; + view all
(2017)
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
The Oncologist
, 22
(9)
pp. 1117-1124.
10.1634/theoncologist.2017-0047.
|
